Global Tuberculosis Control 2010 - Florida Department of Health

US$ billions (constant 2010 US$) b
6
5
4
3
2
1
0
4.0
4.6
5.0
5.3
5.1 5.0
2006 2007 2008 2009 2010 2011
Gap
General healthcare
services:
MDR-TB
General healthcare
services:
DOTS
OR/surveys/other
PPM/PAL/
ACSM/CBC
TB/HIV
MDR-TB
DOTS
US$ billions (constant 2010 US$) b
6
5
4
3
2
1
0
4.0
4.6
5.0
5.3
5.1 5.0
2006 2007 2008 2009 2010 2011
Gap
Unknown c
Global Fund
Grants (excluding
Global Fund)
Loans
Government,
general healthcare
services
(excluding loans)
Government,
NTP budget
(excluding loans)
10 000
Europe b,c Rest of the World b World b
8000
Total
Available
Needed
US$ millions (nominal)
6000
4000
DOTS
MDR-TB d
Laboratories
TB/HIV
2000
0
2010 2015 2010 2015 2010 2015
The quality of financial data reported to WHO has steadily
improved since data were first collected in 2002. At
the same time, reported budgets and expenditures are
not always consistent from one year to the next; assessments
of the funding required – particularly for newer
components of TB control (such as management of
drug-resistant TB) – can appear too low (or, less often,
too high); and persistent funding gaps indicate a need to
strengthen resource mobilization efforts based on con-
vincing plans and well-justified budgets. The WHO TB
planning and budgeting tool was developed in 2006, to
assist with the development of comprehensive plans and
budgets for all relevant components of TB control. When
completed, one advantage of the tool is that it automatically
summarizes NTP budgets and sources of funding
in the format requested on the annual WHO TB data collection
form. Successes in using the tool to help with the
development and budgeting of strategic plans in Bangladesh,
Cambodia and Mongolia between mid-2009 and
mid-2010 are highlighted in .